Company intelligence / Profile preview

Short Wave Pharma

Ramat-Gan, Tel Aviv District, Israel
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

The lead anorexia nervosa program has completed formulation and pre‑clinical work demonstrating safety and effective delivery via buccal film without first‑pass metabolism and is moving into an investigator‑initiated open‑label Phase II trial of psilocybin‑assisted psychotherapy in anorexia nervosa in Israel, with company-sponsored Phase I/IIa planned around 2023–2024.

Therapeutic areas
PsychiatryNeurology
Modalities
Small moleculePsychedelic therapyDrug-device combinationBuccal film delivery therapyNanoparticle (film) delivery therapy
Industry
Biotech
02

Partnerships

Sheba Fund for Health Services and Research and Sheba Medical Center (Department for Eating Disorders) – clinical trial agreement for psilocybin‑assisted psychotherapy in anorexia nervosa (investigator‑initiated open‑label Phase II)Psych Capital / Shortwave Life Sciences (strategic integration and development of clinical programs and IP following acquisition)Vaxil Bio – historical letter of intent for acquisition (non‑binding, for psychedelic formulations and delivery methods)

Beyond the preview

Go deeper on Short Wave Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short Wave Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call